Skip to main content
ALIT $13.80 -5.67%
ALIT logo

ALIT · Alight, Inc. / Delaware

Track ALIT — free
$13.80 -0.83 (-5.67%) At close · Aug 14
Market Cap
$372.97M
Shares
26.94M
All earnings calls

Earnings call · FY2026 Q2

Alight Second Quarter 2026 Earnings Conference Call

Alight Second Quarter 2026 Earnings Conference Call

Concluded Aug 4, 2026 Audio replay Verified speakers
Aug 4, 2026 29:56 34 turns
Period
FY2026 Q2
Runtime
29:56
Sources
4 artifacts

Executive readout · one minute

What matters this quarter

Alight's Q2 2026 revenue declined roughly 3% to $511 million with adjusted EBITDA falling to $92 million (18% margin) from $127 million (24%), as recurring revenue dropped 4% on prior commercial underperformance; management reaffirmed full-year guidance of $2,078–$2,098 million revenue and $400–$415 million adjusted EBITDA while outlining a multi-year turnaround toward 2028 growth and margin expansion.

Commercial execution and retention 11 Guidance and seasonality 11 Liquidity and cash flow 7 Health solutions growth strategy 5 AI and operational transformation 4 Capital allocation 4

Management tone

Positive

Net tone +15 · moderate hedging

Grounding quotes
  • “Revenue for the second quarter was $511 million, a decrease of approximately 3%.”
  • “reflecting the impact of lower than desired commercial execution in prior years”
  • “We are confident that we're doing the right things to drive future long-term performance for shareholders.”
  • “This implies a significant rebound in EBITDA and cash in the fourth quarter, enabling us to set the full-year expectations where we have.”

Forward guidance

4 guided metrics

Management's latest ranges and targets are included below.

Research coverage

4 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $511.00M -3.2% YoY
Diluted EPS -$0.38
Gross margin 27.8% -5.5 pp YoY
Net income -$10.00M

Research materials

Open the source you need; every reader stays inside this workspace.

Key takeaways

What improved, and what deserves a closer read.

Constructive signals

  • Liquidity remained strong at $545 million ($215 million cash plus $330 million undrawn revolver) with year-to-date free cash flow of $101 million.
  • Project revenue grew 11% to $40 million in Q2.
  • Completed the 300th PRT solution and continued activity in wealth/financial advisory.
  • Leadership team is largely in place with refreshed board and increased account coverage from 100 to 500 to support renewal execution.
  • Q3 weakness was framed as seasonal (annual enrollment expense) with a significant rebound in EBITDA and cash expected in Q4.
  • Full-year 2026 guidance maintained: revenue $2,078–$2,098 million and adjusted EBITDA $400–$415 million.

Risks & pressure points

  • Q2 revenue fell approximately 3% to $511 million and recurring revenue declined 4% to $471 million, attributed to lower-than-desired prior-year commercial execution.
  • Adjusted gross profit fell $29 million year-over-year with adjusted gross margin down 440 basis points.
  • Adjusted EBITDA dropped to $92 million from $127 million and adjusted EBITDA margin compressed to 18% from 24%.
  • Adjusted net income fell to $26 million ($0.91 EPS) from $56 million ($2.09 EPS) in Q2 2025.
  • Q3 2026 guided to just $55–$61 million of adjusted EBITDA on $469–$479 million revenue, with management noting the back half carries the biggest P&L impact from prior commercial activity.
  • Compensation Committee lowered the per-share price hurdles on March 2026 TVR awards (e.g., Tranche 1 max VWAP cut from $45.00 to $30.00), a signal that prior stock-price targets were viewed as unattainable.

Key moments

Jump directly to management's words in the synchronized transcript.

Forward guidance

From the 8-K filed Aug 4, 2026.

Metric Guided
Revenues
Third Quarter
$469M – $479M
Adjusted EBITDA
Third Quarter
$55M – $61M
Revenues
Full Year
$2.08B – $2.1B
Adjusted EBITDA
Full Year
$400M – $415M
Full-screen source Call document